Immunotherapy Drugs Market
According to Intent Market Research, the Immunotherapy Drugs Market is expected to grow from USD 247.2 billion in 2023 at a CAGR of 14.6% to touch USD 641.8 billion by 2030. The Immunotherapy Drugs Market is dominated by key players such as, Amgen, AbbVie, Bristol Myers Squibb, Regeneron Pharmaceuticals, Merck, Sanofi, Pfizer, Roche, Novartis, and Eli Lilly.